ZTS
ZTS
NYSE · Pharmaceuticals

Zoetis Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$82.83
-4.48 (-5.13%)
As of May 8, 9:34 PM ET ·
Analyst Consensus
Buy
25
Analysts
High
Coverage
Buy 15 60%
Hold 10 40%
Sell 0 0%
Price Target
Analyst Price Target +153.4% upside
Low Target $137.04
Average Target $209.87
High Target $267.95
Current Price $82.83
Current
$82.83
Target
$209.87
$137.04 $209.87 avg $267.95
Scenario Analysis
Bear Case
$137.04
65.4%
Low target
Base Case
$209.87
+153.4%
Avg target
Bull Case
$267.95
+223.5%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$177.00
-53.2% from high
52-Week Low
$115.25
+-28.1% from low
50-Day SMA
$124.55
-33.5% vs SMA
200-Day SMA
$142.48
-41.9% vs SMA
RSI (14)
62.1
Neutral
Target vs 52W High
$209.87
+18.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
 Hold 45 51% — +0.0%
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
 Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
 Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
 Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
 Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -28.6%